We are live on ! Find out more
TERN

Terns Pharmaceuticals

Delisted

TERN was delisted on the 4th of May, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$11.3M
VC
2
Vivo Capital
California
$7.95M
DM
3
Deerfield Management
New York
$6.97M
Fidelity Investments
4
Fidelity Investments
Massachusetts
$6.89M -$2.05M -479,527 -17%
SCM
5
Suvretta Capital Management
New York
$3.68M
AC
6
Antara Capital
New York
$3.19M +$534K +125,000 +13%
BlackRock
7
BlackRock
New York
$2.19M -$36.7K -8,594 -1%
DCMIC
8
Decheng Capital Management III (Cayman)
Cayman Islands
$2.12M +$3.05M +714,285 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.29M -$535K -125,308 -22%
SB
10
Samsara BioCapital
California
$859K
Geode Capital Management
11
Geode Capital Management
Massachusetts
$532K -$6.93K -1,624 -0.9%
State Street
12
State Street
Massachusetts
$485K +$5.2K +1,218 +0.8%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$364K +$523K +122,573 New
Northern Trust
14
Northern Trust
Illinois
$311K -$30.8K -7,214 -6%
Millennium Management
15
Millennium Management
New York
$263K +$150K +35,229 +66%
CCM
16
CAAS Capital Management
New York
$255K
CAC
17
Cowen and Company
New York
$252K
Renaissance Technologies
18
Renaissance Technologies
New York
$201K +$289K +67,800 New
BCM
19
Bridgeway Capital Management
Texas
$186K -$140K -32,800 -34%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$112K +$10.1K +2,359 +7%
DCM
21
Driehaus Capital Management
Illinois
$104K +$150K +35,100 New
Charles Schwab
22
Charles Schwab
California
$86K
MAM
23
Marquette Asset Management
Minnesota
$65K +$22.1K +5,183 +31%
PPA
24
Parametric Portfolio Associates
Washington
$62K +$36.1K +8,467 +69%
Goldman Sachs
25
Goldman Sachs
New York
$49K +$5.2K +1,219 +8%